View allAll Photos Tagged BioTechnology
High school students participating in the Biotechnology Learning Alliance for Bioscience (LAB) Program at Ohlone College. Get information at www.ohlone.edu/instr/biotech/labprogram/
Resultat del concurs realitzat a www.facebook.com/carlesbarriosdisseny
Resultado del concurso realizado en www.facebook.com/carlesbarriosdisseny
Participants at an immuno-informatics workshop held at ILRI in Nairobi, 4 June 2013 (photo credit: ILRI/Paul Karaimu).
THE BEACONS OF MEDICON VALLEY
Pharmaceutical and biotechnology companies in Greater Copenhagen are a regional success story characterised by a few large companies in pharmaceuticals that are complemented by successful biotechnology companies. But Medicon Valley is more than pharmaceuticals and biotechnology. The region also has successful medical technology companies, growing science parks and the two large materials research facilities Max IV and European Spallation Source, the latter of which is currently under construction in Lund, and ESS data management centre DMSC in Copenhagen.
In this overview, we have chosen important players from six leading areas in Medicon Valley that demonstrate the cluster’s broad scope, in business as in research.
The companies of Medicon Valley are successful, with the four large groups Novo Nordisk, H. Lundbeck, Ferring and LEO Pharma at the forefront. New biotechnology companies are cropping up the Skåne Region, for example in the relatively new science park Medicon Village, and there is a new beacon being raised in the region: with the materials research facilities Max IV and European Spallation Source, ESS.
Industrial foundations have contributed to the stable development of Medicon Valley’s four largest pharmaceutical groups: Novo Nordisk, H. Lundbeck, Ferring and LEO Pharma, all of which are located in and around Copenhagen.
The large pharmaceutical companies have nurtured many researchers and company leaders, which has also benefitted many of the new biotechnology companies that have emerged since the end of the 1990s.
The foundations have also contributed risk capital for new companies and resources for new research, generating a good circular flow in the region.
Increased pressure on prices and the phasing in of a new generation of technology with biological medicines has led to large companies being forced to make cutbacks as well as new investments. As a result, the situation in Medicon Valley can be difficult to interpret.
Six large science parks bring know-how and new companies close together. Three of them are located in and around Copenhagen, one is in Malmö and two are in Lund. The result is a new kind of ”multicellular” big business.
The equilibrium between Medicon Valley’s Zealand and Skåne Regions will be more even with the new beacon being constructed in Lund: the two materials research facilities Max IV and European Spallation Source with data centre in Copenhagen. Life science will be a crucial area. Lund is growing into an even more significant city for research.
State of Medicon Valley 2016
An Analysis of Life Science in Greater Copenhagen
Commissioned and published by: Medicon Valley Alliance.
This analysis has been prepared by Øresundsinstituttet and was
written by Britt Andresen, Johan Wessman, Jenny Andersson,
Anna Palmehag and Thea Wiborg. Layout: Jenny Andersson. November 2016
Link to the full report
www.oresundsinstituttet.org/state-of-medicon-valley-2016-...
Medicine Valley Alliance
Øresundsinstituttet
Copyright: Øresundsinstituttet, (CC BY 3.0)
Creative Commons 3.0 Unported-licens.
07/10/2024. London, United Kingdom. Secretary of State Peter Kyle visits Imperial College London and Multus Biotechnology.
Picture by Alecsandra Dragoi / DSIT
Monsanto Company is a publicly traded American multinational agricultural biotechnology corporation headquartered in Creve Coeur, Missouri. It is a leading producer of genetically engineered (GE) seed and of the herbicide glyphosate, which it markets under the Roundup brand. Founded in 1901 by John Francis Queeny, by the 1940s it was a major producer of plastics, including polystyrene and synthetic fibers. Notable achievements by Monsanto and its scientists as a chemical company included breakthrough research on catalytic asymmetric hydrogenation and being the first company to mass-produce light emitting diodes (LEDs). The company also formerly manufactured controversial products such as the insecticide DDT, PCBs, Agent Orange, and recombinant bovine somatotropin.
Monsanto was among the first to genetically modify a plant cell, along with three academic teams, which was announced in 1983, and was among the first to conduct field trials of genetically modified crops, which it did in 1987. It remained one of the top 10 U.S. chemical companies until it divested most of its chemical businesses between 1997 and 2002, through a process of mergers and spin-offs that focused the company on biotechnology.
Monsanto was a pioneer in applying the biotechnology industry business model to agriculture, using techniques developed by Genentech and other biotech drug companies in the late 1970s in California. In this business model, companies invest heavily in research and development, and recoup the expenses through the use and enforcement of biological patents. Monsanto's application of this model to agriculture, along with a growing movement to create a global, uniform system of plant breeders' rights in the 1980s, came into direct conflict with customary practices of farmers to save, reuse, share and develop plant varieties. Its seed patenting model has also been criticized as biopiracy and a threat to biodiversity. Monsanto's role in these changes in agriculture (which include its litigation and its seed commercialization practices), its current and former agbiotech products, its lobbying of government agencies, and its history as a chemical company, have made Monsanto controversial.
Legal actions and controversies
Monsanto is notable for its involvement in high profile lawsuits, as both plaintiff and defendant. It has been involved in a number of class action suits, where fines and damages have run into the hundreds of millions of dollars, usually over health issues related to its products. Monsanto has also made frequent use of the courts to defend its patents, particularly in the area of agricultural biotechnology.
On 25 May 2013, rallies against Monsanto took place. According to organizers, rallies were planned in 52 countries and 436 cities, and their goal was to protest against Monsanto and the genetically modified food it produces.
The Edmonton Research Park (ERP) also known as the Alberta Research Park encourages growth in technological research, providing a place for businesses to conduct their scientific research in Edmonton.
Participants during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
Participants during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
ILRI scientist Eric Fevre, Suzanne Bertrand, deputy director general for biosciences at ILRI and Steve Kemp, a molecular geneticist at ILRI who leads the biotechnology research project, at a media roundtable on livestock disease research breakthroughs held at ILRI in Nairobi, 30 Apr, 2013 (photo credit: ILRI/Paul Karaimu).
A family gather to meet our sampling team in Horro, some 200 km northwest of Ethiopia's capital, Addis Ababa, Chicken Health 4 Development (CH4D) Project led by ILRI's Biotechnology Theme (photo credit: ILRI/Collins).
Lee Sang-Yup, Distinguished Professor and Dean, Korea Advanced Institute of Science and Technology (KAIST), Republic of Korea speaking during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
Lee Sang-Yup, Distinguished Professor and Dean, Korea Advanced Institute of Science and Technology (KAIST), Republic of Korea speaking during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
The teams reunite with their vehicles midway through a sampling day in Horro, some 200 km northwest of Ethiopia's capital, Addis Ababa, Chicken Health 4 Development (CH4D) Project led by ILRI's Biotechnology Theme (photo credit: ILRI/Collins).
Lee Sang-Yup, Distinguished Professor and Dean, Korea Advanced Institute of Science and Technology (KAIST), Republic of Korea speaking during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
Monsanto Company is a publicly traded American multinational agricultural biotechnology corporation headquartered in Creve Coeur, Missouri. It is a leading producer of genetically engineered (GE) seed and of the herbicide glyphosate, which it markets under the Roundup brand. Founded in 1901 by John Francis Queeny, by the 1940s it was a major producer of plastics, including polystyrene and synthetic fibers. Notable achievements by Monsanto and its scientists as a chemical company included breakthrough research on catalytic asymmetric hydrogenation and being the first company to mass-produce light emitting diodes (LEDs). The company also formerly manufactured controversial products such as the insecticide DDT, PCBs, Agent Orange, and recombinant bovine somatotropin.
Monsanto was among the first to genetically modify a plant cell, along with three academic teams, which was announced in 1983, and was among the first to conduct field trials of genetically modified crops, which it did in 1987. It remained one of the top 10 U.S. chemical companies until it divested most of its chemical businesses between 1997 and 2002, through a process of mergers and spin-offs that focused the company on biotechnology.
Monsanto was a pioneer in applying the biotechnology industry business model to agriculture, using techniques developed by Genentech and other biotech drug companies in the late 1970s in California. In this business model, companies invest heavily in research and development, and recoup the expenses through the use and enforcement of biological patents. Monsanto's application of this model to agriculture, along with a growing movement to create a global, uniform system of plant breeders' rights in the 1980s, came into direct conflict with customary practices of farmers to save, reuse, share and develop plant varieties. Its seed patenting model has also been criticized as biopiracy and a threat to biodiversity. Monsanto's role in these changes in agriculture (which include its litigation and its seed commercialization practices), its current and former agbiotech products, its lobbying of government agencies, and its history as a chemical company, have made Monsanto controversial.
Legal actions and controversies
Monsanto is notable for its involvement in high profile lawsuits, as both plaintiff and defendant. It has been involved in a number of class action suits, where fines and damages have run into the hundreds of millions of dollars, usually over health issues related to its products. Monsanto has also made frequent use of the courts to defend its patents, particularly in the area of agricultural biotechnology.
On 25 May 2013, rallies against Monsanto took place. According to organizers, rallies were planned in 52 countries and 436 cities, and their goal was to protest against Monsanto and the genetically modified food it produces.
High school students participating in the Biotechnology Learning Alliance for Bioscience (LAB) Program at Ohlone College. Get information at www.ohlone.edu/instr/biotech/labprogram/
16 February 2016, Rome, Italy - Farai Muchadeyi, Agricultural Research Council, Pretoria, South Africa. Parallel session 1.2 Facing the challenges of climate change: Adaptation in the livestock and fishery sectors. FAO International Symposium on “The Role of Agricultural Biotechnologies in Sustainable Food Systems and Nutrition". FAO headquarters (Sheikh Zayed Centre).
Photo credit must be given: ©FAO/Pier Paolo Cito. Editorial use only. Copyright ©FAO.
Voronezh is a city and the administrative centre of Voronezh Oblast in southwestern Russia straddling the Voronezh River, located 12 kilometers (7.5 mi) from where it flows into the Don River. The city sits on the Southeastern Railway, which connects western Russia with the Urals and Siberia, the Caucasus and Ukraine, and the M4 highway (Moscow–Voronezh–Rostov-on-Don–Novorossiysk). In recent years the city has experienced rapid population growth, rising in 2021 to 1,057,681, up from 889,680 recorded in the 2010 Census, making it the 14th-most populous city in the country.
From 10 to 17 September 2011, Voronezh celebrated its 425th anniversary. The anniversary of the city was given the status of a federal scale celebration that helped attract large investments from the federal and regional budgets for development.
On December 17, 2012, Voronezh became the fifteenth city in Russia with a population of over one million people.
Today Voronezh is the economic, industrial, cultural, and scientific center of the Central Black Earth Region. As part of the annual tradition in the Russian city of Voronezh, every winter the main city square is thematically drawn around a classic literature. In 2020, the city was decorated using the motifs from Pyotr Ilyich Tchaikovsky's The Nutcracker. In the year of 2021, the architects drew inspiration from Hans Christian Andersen's fairy tale The Snow Queen as well as the animation classic The Snow Queen from the Soviet Union. The fairy tale replica city will feature the houses of Kai and Gerda, the palace of the snow queen, an ice rink, and illumination.
Participants during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
15 February 2016, Rome, Italy - Margaret M. Zeigler, Executive Director, Global Harvest Initiative. FAO International Symposium on “The Role of Agricultural Biotechnologies in Sustainable Food Systems and Nutrition”. Side event. Delivering nutrition, productivity and climate resilience - The Africa Biofortified Sorghum (ABS) project. FAO headquarters (Iran room).
Photo credit must be given: ©FAO/Pier Paolo Cito. Editorial use only. Copyright ©FAO.
Alemanyehu of the socioeconomic team interviews a participating chicken farmer in Horro, some 200 km northwest of Ethiopia's capital, Addis Ababa, Chicken Health 4 Development (CH4D) Project led by ILRI's Biotechnology Theme (photo credit: ILRI/Collins).
15 February 2016, Rome, Italy - Firoz Amijee, Head of Global Registration & Regulatory Affairs, DuPont Pioneer, left, Daniel Kamanga, Director, Communication Program, Africa Harvest, center, and Margaret M. Zeigler, Executive Director, Global Harvest Initiative. FAO International Symposium on “The Role of Agricultural Biotechnologies in Sustainable Food Systems and Nutrition”. Side event. Delivering nutrition, productivity and climate resilience - The Africa Biofortified Sorghum (ABS) project. FAO headquarters (Iran room).
Photo credit must be given: ©FAO/Pier Paolo Cito. Editorial use only. Copyright ©FAO.
Takele Taye, Judy Bettridge and Stacey Lynch examine the comb of a local chicken, 30-31 March 2011, Chicken Health 4 Development (CH4D) Project led by ILRI's Biotechnology Theme (photo credit: ILRI/Collins).
Participants during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
Participants during the Session "World in Transformation: Biotechnology" at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2019. Congress Centre - Centre Hub
Copyright by World Economic Forum / Boris Baldinger
15 February 2016, Rome, Italy - Sir Gordon Conway, Director of Agriculture for Impact and Professor of International Development, Imperial College London and Howard Minigh, President and CEO, CropLife International. FAO International Symposium on “The Role of Agricultural Biotechnologies in Sustainable Food Systems and Nutrition". Side event. Helping farmers grow: Climate change, food security and the technology nexus. FAO headquarters (Sheikh Zayed Centre).
Photo credit must be given: ©FAO/Alessandra Benedetti. Editorial use only. Copyright ©FAO.
Monsanto Company is a publicly traded American multinational agricultural biotechnology corporation headquartered in Creve Coeur, Missouri. It is a leading producer of genetically engineered (GE) seed and of the herbicide glyphosate, which it markets under the Roundup brand. Founded in 1901 by John Francis Queeny, by the 1940s it was a major producer of plastics, including polystyrene and synthetic fibers. Notable achievements by Monsanto and its scientists as a chemical company included breakthrough research on catalytic asymmetric hydrogenation and being the first company to mass-produce light emitting diodes (LEDs). The company also formerly manufactured controversial products such as the insecticide DDT, PCBs, Agent Orange, and recombinant bovine somatotropin.
Monsanto was among the first to genetically modify a plant cell, along with three academic teams, which was announced in 1983, and was among the first to conduct field trials of genetically modified crops, which it did in 1987. It remained one of the top 10 U.S. chemical companies until it divested most of its chemical businesses between 1997 and 2002, through a process of mergers and spin-offs that focused the company on biotechnology.
Monsanto was a pioneer in applying the biotechnology industry business model to agriculture, using techniques developed by Genentech and other biotech drug companies in the late 1970s in California. In this business model, companies invest heavily in research and development, and recoup the expenses through the use and enforcement of biological patents. Monsanto's application of this model to agriculture, along with a growing movement to create a global, uniform system of plant breeders' rights in the 1980s, came into direct conflict with customary practices of farmers to save, reuse, share and develop plant varieties. Its seed patenting model has also been criticized as biopiracy and a threat to biodiversity. Monsanto's role in these changes in agriculture (which include its litigation and its seed commercialization practices), its current and former agbiotech products, its lobbying of government agencies, and its history as a chemical company, have made Monsanto controversial.
Legal actions and controversies
Monsanto is notable for its involvement in high profile lawsuits, as both plaintiff and defendant. It has been involved in a number of class action suits, where fines and damages have run into the hundreds of millions of dollars, usually over health issues related to its products. Monsanto has also made frequent use of the courts to defend its patents, particularly in the area of agricultural biotechnology.
On 25 May 2013, rallies against Monsanto took place. According to organizers, rallies were planned in 52 countries and 436 cities, and their goal was to protest against Monsanto and the genetically modified food it produces.